Teva Pharmaceutical Industries (TEVA) Cash from Operations Growth (1y) (2010 - 2026)
Teva Pharmaceutical Industries (TEVA) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.64 Bn | 87.78 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn | 61.90% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | -22.14% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | 8.20% |
| 5 | United Therapeutics | 22.98 Bn | 20.83 Bn | 648.10 Mn | 0.46% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | -27.49% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 125.00% |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn | 425.00% |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | 450.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.90% |
| Dec 31, 2025 | 101.39% |
| Sep 30, 2025 | -46.75% |
| Jun 30, 2025 | 120.39% |
| Mar 31, 2025 | 15.32% |
| Dec 31, 2024 | -51.44% |
| Sep 30, 2024 | 13,760.00% |
| Jun 30, 2024 | -68.21% |
| Mar 31, 2024 | 14.48% |
| Dec 31, 2023 | 21.69% |
| Sep 30, 2023 | -99.08% |
| Jun 30, 2023 | 163.41% |
| Mar 31, 2023 | -195.92% |
| Dec 31, 2022 | 113.38% |
| Sep 30, 2022 | 2.65% |
| Jun 30, 2022 | -43.58% |
| Mar 31, 2022 | 87.90% |
| Dec 31, 2021 | 37.76% |
| Sep 30, 2021 | 72.31% |
| Jun 30, 2021 | -20.15% |